| __timestamp | Genmab A/S | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 505679000 | 382096000000 |
| Thursday, January 1, 2015 | 487656000 | 345927000000 |
| Friday, January 1, 2016 | 660876000 | 312303000000 |
| Sunday, January 1, 2017 | 874278000 | 325441000000 |
| Monday, January 1, 2018 | 1431159000 | 368298000000 |
| Tuesday, January 1, 2019 | 2386000000 | 492381000000 |
| Wednesday, January 1, 2020 | 3137000000 | 455833000000 |
| Friday, January 1, 2021 | 4181000000 | 526087000000 |
| Saturday, January 1, 2022 | 5562000000 | 633325000000 |
| Sunday, January 1, 2023 | 7630000000 | 729924000000 |
| Monday, January 1, 2024 | 9748000000 | 729924000000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Takeda Pharmaceutical Company Limited and Genmab A/S have demonstrated contrasting strategies in their R&D investments. Takeda, a global leader, has consistently invested heavily, with its R&D expenses growing by approximately 91% from 2014 to 2023. In contrast, Genmab, a smaller yet dynamic player, has shown a remarkable increase of over 1400% in the same period, reflecting its aggressive pursuit of innovation.
While Takeda's R&D spending reached its peak in 2023, Genmab's data for 2024 remains unavailable, leaving room for speculation on its future trajectory. This comparison highlights the diverse approaches within the pharmaceutical industry, where both giants and emerging companies strive to balance risk and reward in their quest for groundbreaking therapies.
Research and Development Expenses Breakdown: Amgen Inc. vs Genmab A/S
Research and Development: Comparing Key Metrics for Gilead Sciences, Inc. and Genmab A/S
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited: Who Invests More in Innovation?
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
R&D Insights: How argenx SE and Genmab A/S Allocate Funds
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Genmab A/S
Research and Development: Comparing Key Metrics for Genmab A/S and Summit Therapeutics Inc.
Analyzing R&D Budgets: Genmab A/S vs Celldex Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs Travere Therapeutics, Inc.